250 related articles for article (PubMed ID: 35003283)
1. Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment.
Kim HJ
Electrolyte Blood Press; 2021 Dec; 19(2):29-37. PubMed ID: 35003283
[TBL] [Abstract][Full Text] [Related]
2. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
3. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease.
Klaerner G; Shao J; Biyani K; Kade M; Kierstead P; Gbur R; Tabakman S; Nguyen S; Buysse J
J Pharmacol Exp Ther; 2020 Dec; 375(3):439-450. PubMed ID: 33033169
[TBL] [Abstract][Full Text] [Related]
5. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.
Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ
Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868
[TBL] [Abstract][Full Text] [Related]
6. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
Goraya N; Simoni J; Jo CH; Wesson DE
Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
[TBL] [Abstract][Full Text] [Related]
7. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
[TBL] [Abstract][Full Text] [Related]
8. Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial.
Mathur VS; Li E; Wesson DE
Nephrol Dial Transplant; 2022 Jun; 37(7):1302-1309. PubMed ID: 34240198
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Acidosis in CKD: Core Curriculum 2019.
Raphael KL
Am J Kidney Dis; 2019 Aug; 74(2):263-275. PubMed ID: 31036389
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Acidosis of CKD: An Update.
Kraut JA; Madias NE
Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
[TBL] [Abstract][Full Text] [Related]
11. Advances in management of chronic metabolic acidosis in chronic kidney disease.
Chen W; Abramowitz MK
Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):409-416. PubMed ID: 31232712
[TBL] [Abstract][Full Text] [Related]
12. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657
[TBL] [Abstract][Full Text] [Related]
13. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
Lancet; 2019 Aug; 394(10196):396-406. PubMed ID: 31248662
[TBL] [Abstract][Full Text] [Related]
15. Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
Mathur VS; Wesson DE; Tangri N; Li E; Bushinsky DA
BMC Nephrol; 2022 Feb; 23(1):82. PubMed ID: 35216581
[TBL] [Abstract][Full Text] [Related]
16. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
Raphael KL
Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
Bushinsky DA
Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
[TBL] [Abstract][Full Text] [Related]
18. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
Trials; 2015 Aug; 16():326. PubMed ID: 26231610
[TBL] [Abstract][Full Text] [Related]
19. Hidden Acid Retention with Normal Serum Bicarbonate Level in Chronic Kidney Disease.
Koh ES
Electrolyte Blood Press; 2023 Jun; 21(1):34-43. PubMed ID: 37434806
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.
Adamczak M; Surma S
Kidney Dis (Basel); 2021 Nov; 7(6):452-467. PubMed ID: 34901192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
